NCino Issues Weaker-Than-Expected 2026 Outlook on International Sales Weakness, Mortgage Headwinds, Morgan Stanley Says

MT Newswires Live
04-03

NCino (NCNO) issued a weaker-than-expected fiscal 2026 outlook due to international booking challenges, a lengthy DocFox integration process, and continued US mortgage market softness, Morgan Stanley said in a note to clients Wednesday.

The company said late Tuesday in its fiscal Q4 results it expects fiscal 2026 non-GAAP diluted EPS of $0.66 to $0.69 on revenue of $574.5 million to $578.5 million. Analysts surveyed by FactSet forecast EPS of $0.88 on revenue of $612.1 million.

Morgan Stanley noted that "the prospect of material subscription revenue growth acceleration (and thereby multiple re-rating) is hard to see."

The investment firm highlighted that while NCino's organic subscription revenue, excluding mortgages, grew 16% in fiscal 2025, the company now expects a sharp slowdown to 9% in fiscal 2026 due to missed internal gross bookings targets internationally and higher churn.

The firm also pointed to DocFox's integration process delaying new subscription revenue growth, with some customers pausing buying decisions until the onboarding process is fully incorporated. While the long-term value proposition of DocFox remains intact, Morgan Stanley said the timeline for meaningful revenue impact is longer than initially expected.

"While we are encouraged by a clean slate on guidance philosophy, we would look to get constructive if we see a path to low-teens organic subscription revenue growth ex. mortgage as the company ramps its new sales force," the note said.

The company also announced a $100 million share repurchase program, which Morgan Stanley interpreted as a signal that management saw the quarter as difficult for investors to digest.

Morgan Stanley kept NCino's equal weight rating and cut the company's price target to $23 from $39.

NCino shares were falling past 23% in recent trading.

Price: 21.59, Change: -6.53, Percent Change: -23.22

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10